Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01010282 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects
A NA study, sponsored by Allergan.
- Completed
- Registry status
- NA
- Development phase
- 288
- Enrollment target
NCT01010282 is a NA study that has completed, run by Allergan. The registered enrollment target is 288 participants.
The verdict
NCT01010282, a NA study, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- NA
- Development phase
- 288 participants
- Enrollment target
Study Summary
This study will evaluate the safety, efficacy, and acceptability of two artificial tears compared to a currently available artificial tear in subjects with dry eye.
Interventions
- DRUG Glycerin and Polysorbate 80 based artificial tear
- DRUG Formulation 1: Carboxymethylcellulose sodium, glycerin and Polysorbate 80, based artificial tear
- DRUG Formulation 2: Carboxymethylcellulose sodium, glycerin, and Polysorbate 80 based artificial tear
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 288 participants |
| Start Date | 2009-11 |
| Est. Completion | 2010-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01010282
The ClinicalTrials.gov registry entry for NCT01010282 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 288 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Glycerin and Polysorbate 80 based artificial tear is the first listed.
NCT01010282 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01010282 about?
NCT01010282 is a clinical study titled "Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects". This study will evaluate the safety, efficacy, and acceptability of two artificial tears compared to a currently available artificial tear in subjects with dry eye.
What is the current status of trial NCT01010282?
This trial is currently completed. It is a NA study. The enrollment target is 288 participants. The study started on 2009-11. Estimated completion is 2010-04.
What interventions are being tested in trial NCT01010282?
The interventions under investigation include: Glycerin and Polysorbate 80 based artificial tear (DRUG), Formulation 1: Carboxymethylcellulose sodium, glycerin and Polysorbate 80, based artificial tear (DRUG), Formulation 2: Carboxymethylcellulose sodium, glycerin, and Polysorbate 80 based artificial tear (DRUG).
Who is sponsoring clinical trial NCT01010282?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.